Health Council Advises Brazil to Break Patent on Three AIDS Drugs

Brazil should break the patents on three HIV/AIDS drugs, whose cost could jeopardize national anti-HIV efforts, a Brazilian health agency has advised .

The recommendation of the Brazilian National Health Council on August 11 would allow the country to make generic HIV drugs that are much cheaper than their brand name versions.


The council says this year alone Brazil will spend US$ 420 million buying drugs for 136,000 patients. Eighty per cent of this will be spent on three drugs: Lopinavir, made by Abbott Laboratories, Nelfinavir by Merck Sharp and Tenofovir by Gilead.


The high cost of brand-name drugs is threatening the sustainability of the Brazilian Program for the Combat of AIDS, which is widely regarded as a model for fighting HIV/AIDS in developing countries, says the council.


For several months now, the government has been negotiating with the pharmaceutical companies that hold the patents to reduce the price of the three drugs.


Under the internationally agreed TRIPS (Trade-Related Aspects of Intellectual Property Rights) Agreement, if the nation’s health is at threat, a developing country can invoke a ‘compulsory license’ allowing them to make drugs without paying the patent-holder.


Brazil’s 1996 intellectual property law also allows patents to be broken when companies use exploitative pricing policies.


Brazil threatened three years ago to break Nelfinavir’s patent, but it eventually negotiated a lower price with the drug company. Earlier this year, the country said it would break the patent on Lopinavir, a threat it dropped after Abbott Laboratories agreed to drop the price of the drug from US$ 1.17 to US$ 0.68 for one capsule.


But last week, an announcement from Brazilian public laboratories that they could make the drug for US$ 0.40 kick-started new negotiations.


Because of intense price negotiations and the volume of drugs it buys, Brazil pays far less than other Latin American countries do for HIV/AIDS drugs. For Lopinavir, for example, Mexico pays US$ 2.40 per capsule and Argentina US$ 1.97.


On August 11, the council recommended that Brazil immediately begin producing the drugs locally, strengthen state laboratories and provide more financial resources for research.


It added that any commercial retaliation on the part of the companies against Brazil for breaking the patents should be considered an illegal act.


Council member Carlos Duarte says the Brazilian health ministry has 30 days to approve or suggest changes to the council’s recommendation.


The National Health Council is composed of representatives of consumers, government officials and companies.
 
This article appeared originally in Science and Development Network – www.scidev.net.

Tags:

You May Also Like

UN: In Brazil, Justice Is Slow and Impunity High

The Special Rapporteur on the independence of judges and lawyers of the United Nations ...

In Brazilian Democracy Law Forbids Making Fun of Electoral Candidates

In Brazil, a never-revoked election law from the era of the Brazilian military dictatorship ...

Brazil Creates Registry for Oil-Sector Small Companies

A national registry in Brazil is going to select products and services suppliers to ...

Brazil and US to Fine Tune Positions Before Next G-20 Summit

Barack Obama, the newly inaugurate US president, wants to work with Brazil on biofuels ...

Brazil’s Major Meat Exporter Buys Meatpackers from Argentina and Uruguay

Brazilian company Marfrig FrigorÀ­ficos e Comércio de Alimentos S.A., one of the largest producers ...

Brazil’s Lula Vows Not to Kill Himself or Take Any Extreme Action

In a speech to Brazil’s Economic and Social Development Council, on Thursday, August 25, ...

AD * Deals on Mobile Phones * AD

It was with a pleasant surprise that I realised the first time that my ...

While Others Might Struggle Brazil Is Ready to Thrive in a Greener Planet

The world leaders have confirmed the prisoner’s dilemma; unfortunately the entire world will face ...

Brazil’s Petrobras Teaches Social Responsibility in London

The Brazilian Petroleum Institute, Pro-Natura International hosted the first Brazilian workshop on Corporate Social ...

Brazilian Premium Cachaça Gets Some Heavy Reinforcement in the US

Karate champion, best-selling author, pirate enthusiast, and motivational speaker, former Philadelphia 76ers owner Pat ...